Recent Advances in Nanotechnology: A Novel Therapeutic System for the Treatment of Alzheimer’s Disease

Author(s): Pallavi Singh Chauhan, Dhananjay Yadav*, Bhupendra Koul, Yugal Kishore Mohanta, Jun-O Jin*

Journal Name: Current Drug Metabolism

Volume 21 , Issue 14 , 2020

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


A amyloid-β (Aβ) plaque formation in the brain is known to be the root cause of Alzheimer’s disease (AD), which affects the behavior, memory, and cognitive ability in humans. The brain starts undergoing changes several years before the actual appearance of the symptoms. Nanotechnology could prove to be an alternative strategy for treating the disease effectively. It encompasses the diagnosis as well as the therapeutic aspect using validated biomarkers and nano-based drug delivery systems, respectively. A nano-based therapy may provide an alternate strategy, wherein one targets the protofibrillar amyloid-β (Aβ) structures, and this is followed by their disaggregation as random coils. Conventional/routine drug therapies are inefficient in crossing the blood-brain barrier; however, this hurdle can be overcome with the aid of nanoparticles. The present review highlights the various challenges in the diagnosis and treatment of AD. Meticulous and collaborative research using nanotherapeutic systems could provide remarkable breakthroughs in the early-stage diagnosis and therapy of AD.

Keywords: Amyloid-β, alzheimer`s, nanoparticles, drug delivery system, drug therapy, diagnosis, neurodegeneration.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2020
Published on: 30 December, 2020
Page: [1144 - 1151]
Pages: 8
DOI: 10.2174/1389200221666201124140518
Price: $65

Article Metrics

PDF: 22